Stay updated on Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial
Sign up to get notified when there's something new on the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page.

Latest updates to the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page
- Check3 days agoChange DetectedA MedlinePlus Genetics resource link about melanoma was removed from the study’s supplementary links.SummaryDifference0.2%

- Check10 days agoChange DetectedThe NIH website-transition announcement banner, including its update link and explanation of SI/AI terminology, was removed from the page.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice about replacing the term “Artificial Intelligence” with “Super Intelligence” appears above the ClinicalTrials.gov page. The previous 403 error message is no longer displayed, and no study details are visible.SummaryDifference2%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

Stay in the know with updates to Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page.